Altitude healing effect in severe asthmatic children.


Journal

Respiratory medicine and research
ISSN: 2590-0412
Titre abrégé: Respir Med Res
Pays: France
ID NLM: 101746324

Informations de publication

Date de publication:
May 2021
Historique:
received: 23 06 2020
revised: 25 11 2020
accepted: 12 12 2020
pubmed: 5 2 2021
medline: 29 10 2021
entrez: 4 2 2021
Statut: ppublish

Résumé

The beneficial effect of a climatic treatment in children with asthma was established quite some time ago, but the mechanism of this beneficial effect has not been fully elucidated. We investigated the role of the cytokines of the TH2 pathway, reactive oxygen species (ROS) and reactive nitrogen species (RNS) over the course of a high-altitude climatic therapy. A group of 67 children originating from various French towns suffering from uncontrolled severe asthma was sent via their medical specialists, to the Briançon climatic area. They were monitored over the course of an entire school year. During this time, they returned home for 15 days during the Christmas holidays. At each stage, assessment of asthma control, lung function examination (peak flow meter and spirometry), and measurement of exhaled NO, ROS and RNS in exhaled breath condensate (EBC), and the level of cytokines in the plasma of the TH2 pathway were carried out. The degree of asthma control improved at high altitude and worsened upon returning home. The average value of the peak expiratory flow also improved during the first 3 months but then worsened upon returning home, while the other spirometric parameters did not change. The level of expired NO and the scores for quality of life underwent a similar change. The level of RNS and ROS in the EBC did not change significantly. Besides, a marked and statistically significant decrease in the level of IL-13 and IL-10 was noted. The beneficial effect of a climatic stay of children suffering from allergic asthma at altitude appears to be linked with less allergenic stimulation.

Sections du résumé

BACKGROUND BACKGROUND
The beneficial effect of a climatic treatment in children with asthma was established quite some time ago, but the mechanism of this beneficial effect has not been fully elucidated. We investigated the role of the cytokines of the TH2 pathway, reactive oxygen species (ROS) and reactive nitrogen species (RNS) over the course of a high-altitude climatic therapy.
METHODS METHODS
A group of 67 children originating from various French towns suffering from uncontrolled severe asthma was sent via their medical specialists, to the Briançon climatic area. They were monitored over the course of an entire school year. During this time, they returned home for 15 days during the Christmas holidays. At each stage, assessment of asthma control, lung function examination (peak flow meter and spirometry), and measurement of exhaled NO, ROS and RNS in exhaled breath condensate (EBC), and the level of cytokines in the plasma of the TH2 pathway were carried out.
RESULTS RESULTS
The degree of asthma control improved at high altitude and worsened upon returning home. The average value of the peak expiratory flow also improved during the first 3 months but then worsened upon returning home, while the other spirometric parameters did not change. The level of expired NO and the scores for quality of life underwent a similar change. The level of RNS and ROS in the EBC did not change significantly. Besides, a marked and statistically significant decrease in the level of IL-13 and IL-10 was noted.
CONCLUSION CONCLUSIONS
The beneficial effect of a climatic stay of children suffering from allergic asthma at altitude appears to be linked with less allergenic stimulation.

Identifiants

pubmed: 33540154
pii: S2590-0412(20)30066-0
doi: 10.1016/j.resmer.2020.100810
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100810

Informations de copyright

Copyright © 2020. Published by Elsevier Masson SAS.

Auteurs

P Quignon (P)

CEMBREU, 35, rue Croix de Bretagne, 05100 Briançon, France. Electronic address: quignon.patrick@orange.fr.

P da Mata (P)

Instituto Clínico de Alergologia, avenue de Berna No. 30, 4(e) B 1050-042, Lisbon, Portugal. Electronic address: pedrodamata@icloud.com.

F Faraj (F)

Centre Les Jeunes Pousses, 34 A, avenue de la République, 05100 Briançon, France.

S Guibert (S)

Centre Les Hirondelles, 17, rue Maisonnette, 05100 Villar-Saint-Pancrace, France.

A Bernard (A)

Centre La Guisane, rue de la Croix de Bretagne, 05100 Villar-Saint-Pancrace, France.

J Léonardi (J)

Centre La Guisane, rue de la Croix de Bretagne, 05100 Villar-Saint-Pancrace, France.

A D Loundou (AD)

Department of Medical Statistics, Aix Marseille University, 27, boulevard Jean-Moulin, 13005 Marseille, France. Electronic address: anderson.loundou@univ-amu.fr.

J Vitte (J)

Aix-Marseille University IRD, AP-HM, MEPHI, Immunology Department, 19-21, boulevard Jean-Moulin, 13005 Marseille, France. Electronic address: jvitte@ap-hm.fr.

D Charpin (D)

Pulmonology Unit, La Timone Hospital, Aix Marseille University, 264, rue Saint-Pierre, Marseille, France. Electronic address: denis-andre.charpin@ap-hm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH